Michael C Edler Selected Research

N-benzyloxycarbonylprolylprolinal

1/2009

Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael C Edler Research Topics

Disease

3	Neoplasms (Cancer) 01/2010 - 08/2005
1	Optic Nerve Diseases (Optic Neuropathy) 01/2019
1	Substance-Related Disorders (Drug Abuse) 11/2018
1	Parkinson Disease (Parkinson's Disease) 11/2018
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 06/2018
1	Leukemia 01/2009
1	Carcinoma (Carcinomatosis) 11/2005
1	Breast Neoplasms (Breast Cancer) 12/2004
1	Lymphoid Leukemia 02/2002
1	Tetraploidy 02/2002

Drug/Important Bio-Agent (IBA)

5	TubulinIBA 01/2010 - 02/2002
2	Boronic AcidsIBA 01/2010 - 09/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2005 - 08/2005
1	Pharmaceutical PreparationsIBA 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 11/2018
1	neurabinIBA 11/2018
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2018
1	Chalcone (Benzalacetophenone)IBA 01/2010
1	N-benzyloxycarbonylprolylprolinalIBA 01/2009
1	tasidotinIBA 01/2009
1	Prolyl OligopeptidasesIBA 01/2009
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 01/2009
1	discodermolideIBA 11/2005
1	dictyostatinIBA 11/2005
1	Colchicine FDA LinkGeneric 09/2005
1	FR 182877IBA 08/2005
1	epothilone AIBA 08/2005
1	vitilevuamideIBA 02/2002

Therapy/Procedure

1	Therapeutics 01/2019